Journal Summary - Discover more summaries and articles from M3 India

Journal Summaries

Neurology

Headache

Comparative study of magnesium, sodium valproate, and concurrent magnesium- sodium valproate therapy in the prevention of migraine headaches: A randomized controlled double-blind trial

The Journal of Headache and Pain | Apr 11, 2021 Headache

Safety and tolerability of eptinezumab in patients with migraine: A pooled analysis of 5 clinical trials

The Journal of Headache and Pain | Apr 03, 2021 Headache

Prospective cohort study of routine exercise and headache outcomes among adults with episodic migraine

Headache: The Journal of Head and Face Pain | Mar 30, 2021 Headache

The association between inflammatory bowel disease and migraine or severe headache among US adults: Findings from the National Health Interview Survey, 2015‐2016

Headache: The Journal of Head and Face Pain | Mar 29, 2021 Headache

Post-reversible cerebral vasoconstriction syndrome headache

The Journal of Headache and Pain | Mar 29, 2021 Headache

Erenumab patient characteristics, medication adherence, and treatment patterns in the United States

Headache: The Journal of Head and Face Pain | Feb 21, 2021 Headache

Identification of neural and psychophysical predictors of headache reduction after cognitive behavioral therapy in adolescents with migraine

Pain | Jan 27, 2021 Headache

Oral rimegepant for preventive treatment of migraine: A phase 2/3, randomized, double-blind, placebo-controlled trial

The Lancet | Dec 20, 2020 Headache

Risk of acute myocardial infarction, heart failure, and death in migraine patients treated with triptans

Headache: The Journal of Head and Face Pain | Oct 09, 2020 Headache

Eptinezumab for the prevention of chronic migraine: efficacy and safety through 24 weeks of treatment in the phase 3 PROMISE-2 (Prevention of migraine via intravenous ALD403 safety and efficacy–2) study

The Journal of Headache and Pain | Oct 09, 2020 Headache

« Prev 1 2 3 4 5 … 24 Next »

Comparative study of magnesium, sodium valproate, and concurrent magnesium- sodium valproate therapy in the prevention of migraine headaches: A randomized controlled double-blind trial

Safety and tolerability of eptinezumab in patients with migraine: A pooled analysis of 5 clinical trials

Prospective cohort study of routine exercise and headache outcomes among adults with episodic migraine

The association between inflammatory bowel disease and migraine or severe headache among US adults: Findings from the National Health Interview Survey, 2015‐2016

Post-reversible cerebral vasoconstriction syndrome headache

Erenumab patient characteristics, medication adherence, and treatment patterns in the United States

Identification of neural and psychophysical predictors of headache reduction after cognitive behavioral therapy in adolescents with migraine

Oral rimegepant for preventive treatment of migraine: A phase 2/3, randomized, double-blind, placebo-controlled trial

Risk of acute myocardial infarction, heart failure, and death in migraine patients treated with triptans

Eptinezumab for the prevention of chronic migraine: efficacy and safety through 24 weeks of treatment in the phase 3 PROMISE-2 (Prevention of migraine via intravenous ALD403 safety and efficacy–2) study

Alternative Therapies and Infection Management

'Weekend Warrior' Trend: Health Perks for Busy Physicians

Top Foods to Combat Winter Illness

Pulmonary Embolism: MCQs Challenge

The Role of Nutrition in Enhancing Fertility for Men and Women

Comparative study of magnesium, sodium valproate, and concurrent magnesium- sodium valproate therapy in the prevention of migraine headaches: A randomized controlled double-blind trial

Safety and tolerability of eptinezumab in patients with migraine: A pooled analysis of 5 clinical trials

Prospective cohort study of routine exercise and headache outcomes among adults with episodic migraine

The association between inflammatory bowel disease and migraine or severe headache among US adults: Findings from the National Health Interview Survey, 2015‐2016

Post-reversible cerebral vasoconstriction syndrome headache

Erenumab patient characteristics, medication adherence, and treatment patterns in the United States

Identification of neural and psychophysical predictors of headache reduction after cognitive behavioral therapy in adolescents with migraine

Oral rimegepant for preventive treatment of migraine: A phase 2/3, randomized, double-blind, placebo-controlled trial

Risk of acute myocardial infarction, heart failure, and death in migraine patients treated with triptans

Eptinezumab for the prevention of chronic migraine: efficacy and safety through 24 weeks of treatment in the phase 3 PROMISE-2 (Prevention of migraine via intravenous ALD403 safety and efficacy–2) study

Alternative Therapies and Infection Management

'Weekend Warrior' Trend: Health Perks for Busy Physicians

Top Foods to Combat Winter Illness

Pulmonary Embolism: MCQs Challenge

The Role of Nutrition in Enhancing Fertility for Men and Women

Select Specialty

Select Topic